Xiamen University

The single-tube, multiplex qPCR assay is the second CE-marked test in the firm's MeltPro line, and identifies 14 genotypes of human papillomavirus.

The test uses multicolor high-resolution melt analysis to detect mutations that lead to a potentially fatal blood disorder particularly common in Asian populations.

Scientists from a number of Chinese research institutions and government agencies have published the first peer-reviewed paper describing the clinical validation of a tuberculosis drug-resistance assay developed by Xiamen-based molecular diagnostics firm Zeesan Biotech.

This article has been updated from a previous version to clarify information regarding the development and commercialization of Zeesan Biotech's assays.

Having recently secured funding from a private investor, moved to the San Francisco Bay Area, and obtained the rights to a key patent covering its core nucleic acid probe technology, molecular diagnostics startup QuanDx is now shifting its attention toward developing clinical ass

Scientists from China's Xiamen University and a startup company called Xiamen Zeesan Biotech have submitted the test to Chinese regulatory officials for approval as a widespread prenatal diagnostic and screening tool for β-thalassemia.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.